부산대학교 도서관

Ferreira I; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; Université Libre de Bruxelles, Brussels, Belgium.; Rueda OM; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.; van der Weyden L; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; Sahni S; Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, United States of America.; Cast O; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.; Wong K; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; Del Castillo Velasco-Herrera M; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; Caldwell H; Edinburgh Pathology, Cancer Research UK Scotland Centre, The University of Edinburgh, Institute of Genetics & Cancer, Edinburgh, United Kingdom.; Boccacino JM; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; Alegbe T; Open Targets, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, United Kingdom.; Mehta I; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; Gunjur A; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; Gupta P; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; Harle V; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; Koga K; Department of Pathology, Faculty of Medicine, Fukuoka University Hospital, Fukuoka, Japan.; Matzusaki I; Department of Diagnostic Pathology, Wakayama Medical University, Wakayama, Japan.; Fujimoto M; Department of Diagnostic Pathology, Wakayama Medical University, Wakayama, Japan.; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.; Wiedemeyer K; Department of Pathology & Laboratory Medicine, The Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.; Departments of Pathology and Dermatology, University of Michigan, Ann Arbor, Michigan, USA.; Stratigos A; 1st Department of Dermatology-Venereology, Andreas Sygros Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.; Oniscu A; Edinburgh Pathology, Cancer Research UK Scotland Centre, The University of Edinburgh, Institute of Genetics & Cancer, Edinburgh, United Kingdom.; Department of Pathology and Cancer Diagnostics, Karolinska University Hospital Solna, Stockholm, Sweden.; Wang K; Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, United States of America.; Department of Comparative Biosciences, University of Illinois Urbana-Champaign, Urbana, IL, USA.; Department of Bioengineering, University of Illinois Urbana-Champaign, Urbana, IL, USA.; Cancer Center at Illinois, University of Illinois Urbana-Champaign, Urbana, IL, USA.; Ruppin E; Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, United States of America.; Demetter P; Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Laboratory for Experiemental Gastroenterology, Université Libre de Bruxelles, Brussels, Belgium.; Pathology department, CerbaPath, Division CMP, Brussels, Belgium.; Frayling IM; Inherited Tumour Syndromes Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK.; Arends MJ; Edinburgh Pathology, Cancer Research UK Scotland Centre, The University of Edinburgh, Institute of Genetics & Cancer, Edinburgh, United Kingdom.; Brenn T; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.; Department of Pathology & Laboratory Medicine, The Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.; Adams DJ; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom. da1@sanger.ac.uk.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

van der Weyden, L; Rust, A G; McIntyre, R E; Robles-Espinoza, C D; del Castillo Velasco-Herrera, M; Strogantsev, R; Ferguson-Smith, A C; McCarthy, S; Keane, T M; Arends, M J; Adams, D J

Oncogene. 1/17/2013, Vol. 32 Issue 3, p397-402. 6p.

Del Castillo Velasco-Herrera, M; Van der Weyden, L; Nsengimana, J; Speak, AO; Sjöberg, MK; Bishop, DT; Jönsson, G; Newton-Bishop, J; Adams, DJ

Mol Oncol
Molecular Oncology, Vol 12, Iss 2, Pp 239-255 (2018)
Molecular Oncology

Adams DJ; Wellcome Sanger Institute, Cambridge, UK. da1@sanger.ac.uk.; Barlas B; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; McIntyre RE; Wellcome Sanger Institute, Cambridge, UK.; Salguero I; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.; van der Weyden L; Wellcome Sanger Institute, Cambridge, UK.; Barros A; Wellcome Sanger Institute, Cambridge, UK.; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.; Vicente JR; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Karimpour N; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Haider A; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Ranzani M; Wellcome Sanger Institute, Cambridge, UK.; Turner G; Wellcome Sanger Institute, Cambridge, UK.; Thompson NA; Wellcome Sanger Institute, Cambridge, UK.; Harle V; Wellcome Sanger Institute, Cambridge, UK.; Olvera-León R; Wellcome Sanger Institute, Cambridge, UK.; Robles-Espinoza CD; Wellcome Sanger Institute, Cambridge, UK.; Laboratorio Internacional de Investigación Sobre el Genoma Humano, Universidad Nacional Autónoma de México, Santiago de Querétaro, México.; Speak AO; Wellcome Sanger Institute, Cambridge, UK.; Geisler N; Wellcome Sanger Institute, Cambridge, UK.; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.; Weninger WJ; Division of Anatomy, MIC, Medical University of Vienna, Wien, Austria.; Geyer SH; Division of Anatomy, MIC, Medical University of Vienna, Wien, Austria.; Hewinson J; Wellcome Sanger Institute, Cambridge, UK.; Karp NA; Wellcome Sanger Institute, Cambridge, UK.; Fu B; Wellcome Sanger Institute, Cambridge, UK.; Yang F; Wellcome Sanger Institute, Cambridge, UK.; Kozik Z; Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London, UK.; Choudhary J; Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London, UK.; Yu L; Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London, UK.; van Ruiten MS; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Rowland BD; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lelliott CJ; Wellcome Sanger Institute, Cambridge, UK.; Del Castillo Velasco-Herrera M; Wellcome Sanger Institute, Cambridge, UK.; Verstraten R; Wellcome Sanger Institute, Cambridge, UK.; Bruckner L; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.; Henssen AG; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Rooimans MA; Department of Human Genetics, Section of Oncogenetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; de Lange J; Department of Human Genetics, Section of Oncogenetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Mohun TJ; Division of Developmental Biology, MRC, National Institute for Medical Research, London, UK.; Arends MJ; Division of Pathology, Cancer Research UK Scotland Centre, Institute of Genetics & Cancer The University of Edinburgh, Edinburgh, UK.; Kentistou KA; MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, UK.; Coelho PA; Department of Genetics, University of Cambridge, Cambridge, UK.; Zhao Y; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Zecchini H; Metabolic Research Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, UK.; Perry JRB; MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, UK.; Metabolic Research Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, UK.; Jackson SP; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Institute, Cambridge, UK.; Balmus G; Wellcome Sanger Institute, Cambridge, UK. gb318@cam.ac.uk.; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK. gb318@cam.ac.uk.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. gb318@cam.ac.uk.; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. gb318@cam.ac.uk.; Department of Molecular Neuroscience, Transylvanian Institute of Neuroscience, Cluj-Napoca, Romania. gb318@cam.ac.uk.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Roumeliotis, TI; Williams, SP; Gonçalves, E; Alsinet, C; Del Castillo Velasco-Herrera, M; Aben, N; Ghavidel, FZ; Michaut, M; Schubert, M; Price, S; Wright, JC; Yu, L; Yang, M; Dienstmann, R; Guinney, J; Beltrao, P; Brazma, A; Pardo, M; Stegle, O; Adams, DJ; Wessels, L; Saez-Rodriguez, J; McDermott, U; Choudhary, JS

Cell Rep
Cell Reports, Vol 20, Iss 9, Pp 2201-2214 (2017)
Cell Reports, 20 (9)
Cell reports 20(9), 2201-2214 (2017). doi:10.1016/j.celrep.2017.08.010
Cell Reports